Skip to content
10-K

Annual Report

Harvard Apparatus Regenerative Technology, Inc. HRGN

0001437749-26-009079

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 17.58M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$3.83M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.85M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.35M
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.49M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.06M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.22M
Stockholders Equity FY 2025 · Dec 31, 2023 $1.65M
Current Liabilities FY 2025 · Dec 31, 2025 $1.53M
Current Liabilities FY 2025 · Dec 31, 2024 $1.02M
Total Liabilities FY 2025 · Dec 31, 2025 $1.62M
Total Liabilities FY 2025 · Dec 31, 2024 $1.22M
Current Assets FY 2025 · Dec 31, 2025 $1.83M
Current Assets FY 2025 · Dec 31, 2024 $3.23M
Total Assets FY 2025 · Dec 31, 2025 $2.68M
Total Assets FY 2025 · Dec 31, 2024 $4.44M
Eps Basic FY 2025 · Dec 31, 2025 −$0.42
Eps Basic FY 2025 · Dec 31, 2024 −$0.52
Rd Expense FY 2025 · Dec 31, 2025 $2.65M
Rd Expense FY 2025 · Dec 31, 2024 $2.31M
Net Income FY 2025 · Dec 31, 2025 −$6.87M
Net Income FY 2025 · Dec 31, 2024 −$7.73M
Operating Income FY 2025 · Dec 31, 2025 −$6.92M
Operating Income FY 2025 · Dec 31, 2024 −$7.73M
Cost Of Revenue FY 2025 · Dec 31, 2025 $646K
Cost Of Revenue FY 2025 · Dec 31, 2024 $270K
Revenue FY 2025 · Dec 31, 2025 $704K
Revenue FY 2025 · Dec 31, 2024 $430K